These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2976891)

  • 1. Protective effect of verapamil in experimental myocardial ischaemia: an electron microscopic investigation.
    Georgescu L; Rottenberg N; Avram R; Potencz E; Dema E; Petraşcu-Stefanovici O; Lazăr E
    Morphol Embryol (Bucur); 1988; 34(4):277-80. PubMed ID: 2976891
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
    Tereshchenko VP; Nizhenkovskaia IV
    Vrach Delo; 1983 May; (5):19-21. PubMed ID: 6880160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphofunctional analysis of the efficacy of verapamil in experimental ischemia].
    Bratus' VV; Sergienko OV; Bezus'ko AG; Shavaran SS
    Vrach Delo; 1989 Jul; (7):69-72. PubMed ID: 2800508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
    Paperno AA; Kovalev GV; Gurbanov KG
    Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural and biochemical alterations induced by propranolol treatment in experimental myocardial ischaemia.
    Laky D; Constantinescu S; Filipescu G; Constantinescu NM; Ratea E; Hălălău F
    Morphol Embryol (Bucur); 1981; 27(3):249-53. PubMed ID: 6460936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of verapamil cardioplegia on myocardial ultrastructure.
    Atkinson JB; Rybicka K; Huddleston CB; Starnes VA; Prager RL; Virmani R
    Am J Cardiovasc Pathol; 1988; 2(1):69-77. PubMed ID: 3207491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative evaluation of the anti-ischemic action of verapamil in different models of myocardial ischemia].
    Gurbanov KK; Kovalev GV; Paperno AA
    Farmakol Toksikol; 1991; 54(4):21-3. PubMed ID: 1786814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardioprotective effect of verapamil.
    Nayler WG; Slade AM
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():75-87. PubMed ID: 6956475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial hypertrophy due to isoproterenol. The preventive action of verapamil].
    Póvoa R; Manzoli MT; Ferreira C; Murad N; Simões M; Ferreira C; Luna B
    Rev Port Cardiol; 1995 Nov; 14(11):847-51. PubMed ID: 8541062
    [No Abstract]   [Full Text] [Related]  

  • 12. [The verapamil correction of postresuscitation damages to the heart].
    Korpacheva OV; Dolgikh VT
    Anesteziol Reanimatol; 1996; (5):48-51. PubMed ID: 9027256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitochondrial functionality and homeostasis of CA during experimental ischaemia. Protective action of verapamil (author's transl)].
    Ferrari R; Bongrani S; Di Lisa F; Raddino R
    G Ital Cardiol; 1980; 10(7):877-88. PubMed ID: 7461336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of agents used in the therapy of acute ischemic heart disease on the histomorphological changes in the myocardium in acute dystrophy].
    Nikulin AA; Chernov IP
    Farmakol Toksikol; 1979; 42(4):371-6. PubMed ID: 477957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of the action of plasmin in myocardial damage due to coagulation].
    Monastyrskiĭ VA; Voroniak MI; Birka II; Gaĭda AV; Magerovskiĭ IuV
    Vrach Delo; 1988 Mar; (3):70-3. PubMed ID: 2969161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    Litvitskiĭ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dibunol and isoptin on the creatine kinase and myoglobin content of the blood serum in dogs undergoing postischemic coronary reperfusion].
    Golikov AP; Avilova OA; Polumiskov VIu; Berestov AA; Konorev EA
    Biull Eksp Biol Med; 1987 Oct; 104(10):413-6. PubMed ID: 3676455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
    Grigor'eva NN; Gichka SG; Stepaniuk GI; Degtiareva LV
    Vrach Delo; 1984 Oct; (10):91-3. PubMed ID: 6516320
    [No Abstract]   [Full Text] [Related]  

  • 19. [The activity of mitochondrial enzymes in the myocardium in chronic coronary failure during the administration of antianginal agents].
    Voronkov GS; Evstratova IN
    Eksp Klin Farmakol; 1992; 55(6):17-9. PubMed ID: 1305865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of drugs on the resistance of the myocardium to hypoxia].
    Spasov AA
    Biull Eksp Biol Med; 1988 Jan; 105(1):110-2. PubMed ID: 3337872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.